Devon Energy Corp. (NYSE: DVN) today announced it will report fourth-quarter and full-year 2024 results on Tuesday, Feb. 18, after the close of U.S. financial markets. The earnings release and ...

Covering 2023 to 2025, the 4Q 2024 edition of World Fab Forecast report shows that the global semiconductor industry plans to ...

Technological Advancements: Innovations in CGM technology, including non-invasive glucose monitoring and seamless integration with mobile applications, are improving the convenience, accuracy, and ...

“I am very proud of the Symbotic team for this important achievement. Diversity and inclusion are the foundation of our culture and fuels our innovation to drive meaningful change within the robotics ...

It’s with great pleasure that we announce Jim Whitlinger as the company’s new chief financial officer,” said Diana Reid, Chief Executive Officer of Freddie Mac. “Jim is a proven leader with more than ...

The promotions span across six practice areas and three regions to drive growth in 2025 and beyond ...

Aegis Capital Corp. is acting as the sole book-running manager for the Offering on a firm commitment basis. Sichenzia Ross Ference Carmel LLP is acting as counsel to the Company. Kaufman & Canoles, ...

About NXC-201 NXC-201 is a sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy. Initial data from Phase 1b/2 ex-U.S. study NEXICART-1 has demonstrated high complete ...

Submitted Patent Application to Protect P-300 Manufacturing Know-How Expanding Downstream Focus to Space & eVTOL Industries through High Compatibility with Solid-State Batteries TORONTO, Jan. 07, 2025 ...

Mark Becks, CFA, (734) 457-9538 [email protected] About La-Z-Boy: La-Z-Boy Incorporated brings the transformational power of comfort to people, homes, and communities around the world - a ...

A live webcast of the presentation will be available on the investor section of the Anaptys website at A replay of the webcast will be available for at least 30 days following the event. About ...

LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced the appointment of ...